Quest Diagnostics Incorporated (DGX) - Product Pipeline Analysis
GlobalData
December 29, 2011 39 Pages - SKU: GBDT6738787
|
|
Quest Diagnostics Incorporated (DGX) - Product Pipeline Analysis
Summary
Quest Diagnostics Incorporated (Quest), a medical diagnostics company, is a provider of diagnostic testing services to the patients and physicians in the US through network of laboratories and company-owned patient service centers. The company provides a comprehensive suite of services, including: clinical testing, with gene-based and other esoteric test, anatomic pathology services. The company's core focus areas include Diagnostic Testing & Services, and Clinical Trials. Quest Diagnostics is one of the largest providers of global central laboratory services.
This report is a source for data, analysis and actionable intelligence on the Quest Diagnostics Incorporated portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? - identify, understand and capitalize.
|
- Quest Diagnostics Incorporated - Business Description
- Key Facts
- Quest Diagnostics Incorporated - Major Products and Services
- Quest Diagnostics Incorporated Pipeline Products by Equipment Type
- Quest Diagnostics Incorporated Pipeline Products by Development Stage
- Quest Diagnostics Incorporated Pipeline Products by Therapy Area
- Quest Diagnostics Incorporated Pipeline Products by Milestone Summary
- Clost. Difficile Assay
- Clost. Difficile Assay Product Status
- Clost. Difficile Assay Product Description
- Diagnostic Test - MRSA
- Diagnostic Test - MRSA Product Status
- Diagnostic Test - MRSA Product Description
- Enterovirus Assay
- Enterovirus Assay Product Status
- Enterovirus Assay Product Description
- High Sensitivity Glucose Test - Room Temperature Version
- High Sensitivity Glucose Test - Room Temperature Version Product Status
- High Sensitivity Glucose Test - Room Temperature Version Product Description
- High Sensitivity Glucose Test - Room Temperature Version Product Patent Details
- Simplexa Flu A/B & RSV Direct Test
- Simplexa Flu A/B & RSV Direct Test Product Status
- Simplexa Flu A/B & RSV Direct Test Product Description
- Simplexa Flu A/B & RSV Direct Test Product Milestone
- Simplexa Group A Strep Direct Assay
- Simplexa Group A Strep Direct Assay Product Status
- Simplexa Group A Strep Direct Assay Product Description
- Simplexa HSV 1&2 Direct Test
- Simplexa HSV 1&2 Direct Test Product Status
- Simplexa HSV 1&2 Direct Test Product Description
- Quest Diagnostics Incorporated - Key Competitors
- Quest Diagnostics Incorporated - Key Employees
- Quest Diagnostics Incorporated - Key Employee Biographies
- Quest Diagnostics Incorporated - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Quest Diagnostics Incorporated, Recent Developments
- Oct 25, 2011: Quest Diagnostics Reports Revenues Of $1.9 Billion In Q3 2011
- Jul 20, 2011: Quest Diagnostics Reports Net Revenues Of $1.9 Billion In Q2 2011
- Jun 22, 2011: Quest Diagnostics Launches New Version Of Gazelle For Google Android Smartphones
- Jun 09, 2011: Quest Diagnostics Wins Gold MDEA For Simplexa Molecular Test In Vitro Diagnostics Category
- May 09, 2011: Quest Diagnostics Reaches Agreement In Principle To Settle California Lawsuit Related To Medi-Cal Billing
- Apr 28, 2011: Quest Diagnostics’s Simplexa Test For Epstein Barr And BK Viruses Receives CE Mark For Sale In Europe
- Apr 20, 2011: Quest Diagnostics Reports Net Revenues Of $1.82 Billion In Q1 2011
- Apr 18, 2011: Celera Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition By Quest Diagnostics
- Apr 12, 2011: Brower Piven Files Class Action Suit Against Celera
- Feb 10, 2011: Quest Diagnostics And Withings Announce Availability Of Integrated WiFi Weight Tracking For Gazelle Mobile Health Platform
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Quest Diagnostics Incorporated, Key Facts
- Quest Diagnostics Incorporated Key Pipeline Products by Equipment Type
- Quest Diagnostics Incorporated Key Pipeline Products by Therapy Area
- Quest Diagnostics Incorporated Key Pipeline Products by Development Stage
- Quest Diagnostics Incorporated, Key Facts
- Quest Diagnostics Incorporated, Major Products and Services
- Quest Diagnostics Incorporated Number of Pipeline Products by Equipment Type
- Quest Diagnostics Incorporated Pipeline Products by Equipment Type
- Quest Diagnostics Incorporated Number of Pipeline Products by Development Stage
- Quest Diagnostics Incorporated Pipeline Products by Development Stage
- Quest Diagnostics Incorporated Number of Pipeline Products by Therapy Area
- Quest Diagnostics Incorporated Pipeline Products by Therapy Area
- Quest Diagnostics Incorporated Number of Pipeline Products By Milestone Summary
- Quest Diagnostics Incorporated Pipeline Products by Milestone Summary
- Clost. Difficile Assay - Product Status
- Clost. Difficile Assay - Product Description
- Diagnostic Test - MRSA - Product Status
- Diagnostic Test - MRSA - Product Description
- Enterovirus Assay - Product Status
- Enterovirus Assay - Product Description
- High Sensitivity Glucose Test - Room Temperature Version - Product Status
- High Sensitivity Glucose Test - Room Temperature Version - Product Description
- High Sensitivity Glucose Test - Room Temperature Version - Patent Details
- Simplexa Flu A/B & RSV Direct Test - Product Status
- Simplexa Flu A/B & RSV Direct Test - Product Description
- Simplexa Flu A/B & RSV Direct Test - Product Milestone
- Simplexa Group A Strep Direct Assay - Product Status
- Simplexa Group A Strep Direct Assay - Product Description
- Simplexa HSV 1&2 Direct Test - Product Status
- Simplexa HSV 1&2 Direct Test - Product Description
- Quest Diagnostics Incorporated, Key Employees
- Quest Diagnostics Incorporated, Key Employee Biographies
- Quest Diagnostics Incorporated, Subsidiaries
- List of Figures
- Quest Diagnostics Incorporated Key Pipeline Products by Equipment Type
- Quest Diagnostics Incorporated Pipeline Products by Equipment Type
- Quest Diagnostics Incorporated Pipeline Products by Development Stage
- Quest Diagnostics Incorporated Pipeline Products by Therapy Area
- Quest Diagnostics Incorporated Pipeline Products by Milestone Summary
Share this report
Other tasks Related Markets Diagnostics Company Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|